FreeTender
Accepting bidsitbItaly

Italy – Laboratory reagents – REAGENTI NGS 3 LOTTI

Issued by IRCCS FONDAZIONE PASCALE · via TED — Tenders Electronic Daily (EU)

Published
18 Sept 2026
Closes
19 Oct 2026, 23:59 UTC
Value
EUR 1,364,092
Reference
643494-2026
Location
Italy
Sector
Healthcare & Pharma
Type
goods

Details

GARA EUROPEA A PROCEDURA APERTA TELEMATICA PER LA FORNITURA IN SOMMINISTRAZIONE QUADRIENNALE DI REAGENTI DESTINATI AD INDAGINI PER ANALISI NGS”, SUDDIVISA IN N. 3 LOTTI

Lots Lot 1 — reagenti destinati a indagini molecolari basate sulla tecnologia di sequenziamento NGS, per l’analisi di trascritti di fusione, mutazioni (SNP, INDEL) e CNV di geni coinvolti nelle patologie onco-ematologiche (estimated 1364092.00) Lot 2 — reagenti destinati ad indagini molecolari basate su tecnologia di sequenziamento NGS, per la determinazione della presenza o assenza di clonalità e ipermutazione somatica e per il monitoraggio della malattia minima residua nelle malattie linfoproliferative a cellule B e T (estimated 402968.00) Lot 3 — reagenti per il sequenziamento di nuova generazione (NGS) destinati alla creazione di saggi custom per l'analisi di mutazioni puntiformi (SNV), inserzioni/delezioni (Indel), variazioni del numero di copie (CNV) e trascritti di fusione in geni coinvolti nelle patologie onco-ematologiche, comprensiva di una piattaforma software per l'analisi bioinformatica secondaria e terziaria (estimated 397106.00)

Buyer: IRCCS FONDAZIONE PASCALE

Buyer country: ITA

Procedure: open

CPV code: 33696500

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

There are 194 open Healthcare & Pharma tenders in Italy. This one closes in 32 days.

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →